The Nippon India NIFTY Pharma ETF, managed by Nippon Life India Asset Management Limited, is an open-ended fund that passively tracks the Nifty Pharma TRI, focusing on pharmaceutical securities.

Utilizing a passive investment strategy, this ETF replicates the Nifty Pharma Index by investing in its constituent securities in the same proportions, ensuring effective benchmark tracking.

The portfolio is heavily concentrated in the pharmaceuticals sector, with top holdings like Sun Pharmaceutical Industries at 21.98% and Cipla at 11.43%, highlighting potential concentration risk.

Performance metrics indicate a one-year change of -7.9%, while the three-year CAGR stands at 18.9%, reflecting mixed performance against market volatility and sector dynamics.

With a fund size of ₹993.85 Cr and a low expense ratio of 0.21%, it offers investors efficient exposure to the pharmaceutical sector, managed by experienced fund manager Jitendra Tolani since February 2025.